Revvity reported $12.36B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Adcock Ingram Holdings ZAR 8.74B 388.13M Dec/2024
Agilent USD 12.23B 68M Jul/2025
Align Technology USD 6.22B 116.27M Jun/2025
Bio Techne USD 2.56B 86.39M Jun/2025
Bio-Rad Laboratories USD 10.21B 687.2M Jun/2025
Bruker USD 6.34B 406.7M Jun/2025
Celltrion KRW 20.96T 96.41B Mar/2025
Charles River Laboratories USD 7.56B 21.82M Jun/2025
Cspc Pharmaceutical CNY 44.39B 3.51B Dec/2024
Danaher USD 81.62B 2.5B Jun/2025
Dentsply International USD 6.07B 19M Jun/2025
Dianthus Therapeutics USD 326.08M 47.93M Jun/2025
Divis Laboratories Ltd 169.32B 13.46B Mar/2025
Edwards Lifesciences USD 13.02B 33M Mar/2025
Exact Sciences USD 5.8B 86.29M Jun/2025
Hologic USD 8.81B 261M Jun/2025
Illumina USD 6.09B 95M Jun/2025
Intuitive Surgical USD 20.16B 942.8M Jun/2025
IQVIA Holdings USD 28.63B 1.31B Jun/2025
Kangmei Pharma CNY 13.64B 69.1M Jun/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 869.6M 37.58M Jun/2025
Laboratory Of America USD 18.06B 456.1M Jun/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 65.33M 6.17M Dec/2024
Mettler Toledo International USD 3.4B 165.79M Jun/2025
Myriad Genetics USD 1.01B 21.5M Mar/2025
Neuren Pharmaceuticals AUD 409.71M 181.55M Dec/2024
Organigram Holdings CAD 564.62M 85.41M Jun/2025
Pharma Mar EUR 348.25M 14.75M Jun/2025
Qiagen NV USD 5.82B 278.39M Jun/2025
Quest Diagnostics USD 15.97B 172M Jun/2025
Quidel USD 6.38B 82.5M Jun/2025
Repligen USD 2.85B 22.48M Mar/2025
Revvity USD 12.36B 2.06M Jun/2025
Sartorius EUR 10.03B 85.1M Jun/2025
Sino Biopharmaceutical CNY 65.41B 1.3B Dec/2024
Thermo Fisher Scientific USD 101.23B 2.19B Jun/2025
Tilray USD 4.19B 70.11M Nov/2024
Waters USD 4.72B 126.5M Jun/2025
Zz Pientze Pharmaceu 18.71B 224.21M Jun/2025